Optiver Trims argenex Stake as Institutional Rebalancing Hits Biotech
Optiver Holding B.V. reduced its position in argenex SE (ARGX) by 34.9% during the third quarter, according to recent SEC filings. The firm sold 6,066 shares, leaving it with a remaining stake valued at approximately $8.35 million.